StonvexLoading…
StonvexStonvexStonvexCore line items from TRMK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $948.62M | $960.33M | $878.83M | $541.83M |
Operating Income | $274.68M | $34.06M | $181.03M | $59.10M |
Net Income | $224.13M | $223.01M | $165.49M | $71.89M |
EPS (Diluted) | $3.70 | $3.63 | $2.70 | $1.17 |
Total Assets | $18.93B | $18.15B | $18.72B | $18.02B |
Total Liabilities | $16.80B | $16.19B | $17.06B | $16.52B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $231.95M | $93.44M | $156.81M | $269.89M |
Shares Outstanding | 59.01M | 61.01M | 61.07M | 60.98M |